Using digital speech analysis to detect Alzheimer's disease early.
Connected Language and Speech Along the Spectrum of Alzheimer’s Disease and Related Dementias: Digital Assessment and Monitoring.
This study is looking at how everyday speech can help spot early signs of Alzheimer's and related dementias, using recordings and smart technology, to make it easier for people, especially those from underserved communities, to get involved in research and understand how the disease progresses.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-11056790 on NIH RePORTER |
What this research studies
This research focuses on improving the early detection of Alzheimer's disease and related dementias by analyzing everyday speech patterns through digital recordings. By utilizing existing speech samples and advanced technology like natural language processing and machine learning, the study aims to create a non-invasive and accessible method for monitoring cognitive function. This approach seeks to enhance recruitment for clinical trials and provide valuable insights into the progression of Alzheimer's disease, particularly for individuals from underserved communities.
Who could benefit from this research
Good fit: Ideal candidates for this research include adults aged 21 and older who are at risk for Alzheimer's disease or related dementias.
Not a fit: Patients who are already experiencing significant cognitive decline or have a confirmed diagnosis of advanced Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate detection of Alzheimer's disease, allowing for timely interventions.
How similar studies have performed: Other research has shown promise in using digital speech analysis for cognitive assessment, indicating that this approach could be effective.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Mueller, Kimberly D — University of Wisconsin-Madison
- Study coordinator: Mueller, Kimberly D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.